Clinical Report: The Role of Lactylation in Tumor Microenvironment Dynamics
Overview
This review highlights the role of protein lactylation as a critical epigenetic mechanism linking metabolic changes to immune suppression in the tumor microenvironment.
Background
Protein lactylation is a novel post-translational modification that connects cellular metabolism to gene regulation, particularly in cancer. The accumulation of lactate in the tumor microenvironment, a result of the Warburg effect, creates conditions conducive to lactylation, influencing both tumor cell behavior and immune responses.
Data Highlights
No numerical data or trial data presented in the source material.
Key Findings
Lactylation promotes tumor cell malignancy by reshaping chromatin accessibility and enhancing oncogenic signaling pathways.
It drives macrophages toward an M2-like immunosuppressive phenotype and enhances the function of regulatory T cells (Tregs).
Lactylation induces dysfunction and exhaustion in CD8+ T cells, contributing to immune evasion.
Current evidence on lactylation is largely correlative, necessitating further research to establish causality.
Clinical Implications
Clinicians should consider the metabolic-epigenetic-immune interactions when developing treatment plans for cancer patients.
Conclusion
The lactylation axis represents a significant link between metabolism and immune suppression in cancer. Further research is needed to fully elucidate its mechanisms.
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.
